SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-041825
Filing Date
2021-02-12
Accepted
2021-02-12 17:06:36
Documents
7
Effectiveness Date
2021-02-12

Document Format Files

Seq Description Document Type Size
1 S-8 d137290ds8.htm S-8 80246
2 EX-5.1 d137290dex51.htm EX-5.1 12208
3 EX-23.1 d137290dex231.htm EX-23.1 1724
4 EX-99.2(A) d137290dex992a.htm EX-99.2(A) 122806
5 EX-99.3 d137290dex993.htm EX-99.3 75953
6 GRAPHIC g137290dsp07.jpg GRAPHIC 3456
7 GRAPHIC g137290dsp08.jpg GRAPHIC 2200
  Complete submission text file 0001193125-21-041825.txt   302032
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-253085 | Film No.: 21629289
SIC: 2834 Pharmaceutical Preparations